Related Experiment Videos
Efficacy of INSURE during nasal CPAP in preterm infants with respiratory distress syndrome
F Leone1, D Trevisanuto, F Cavallin
1Department of Pediatrics, Padua University, Padua, Italy.
Insights
The INSURE (INtubation, SURfactant, Extubation) method, combined with nasal CPAP (nCPAP), improves oxygenation and reduces respiratory issues in preterm infants with respiratory distress syndrome (RDS). This approach is more effective than rescue surfactant treatment during mechanical ventilation.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Critical Care
Background:
- Respiratory distress syndrome (RDS) is a common condition in preterm infants.
- Nasal continuous positive airway pressure (nCPAP) is a standard treatment for RDS.
- The INSURE (INtubation, SURfactant, Extubation) procedure is an adjunct to nCPAP for RDS management.
Purpose of the Study:
- To evaluate the efficacy of the INSURE method when administered during nCPAP treatment for RDS in preterm infants.
- To compare respiratory outcomes, including oxygenation and comorbidities, between infants treated with INSURE during nCPAP and those receiving rescue surfactant therapy during mechanical ventilation.
Main Methods:
- A comparative study of 824 preterm infants admitted to Padua University Hospital (2007-2009).
- 209 infants received "rescue" surfactant treatment, with 42 treated with INSURE during nCPAP.
- INSURE-treated infants were matched with controls receiving surfactant during mechanical ventilation based on key perinatal factors.
Main Results:
- Infants treated with INSURE during nCPAP showed significantly improved oxygenation (post-treatment FiO2 and a-A pO2) compared to controls (P=0.03).
- Improved oxygenation was sustained in the days following treatment.
- The INSURE group experienced fewer respiratory comorbidities, including pneumothorax, bronchopulmonary dysplasia (BPD), and BPD with death (P=0.04).
Conclusions:
- INSURE combined with nCPAP is more effective than rescue surfactant administration during mechanical ventilation for improving and maintaining oxygenation in preterm infants with RDS.
- This strategy significantly reduces the incidence of respiratory comorbidities.
- Early INSURE administration during nCPAP represents a superior treatment approach for neonatal respiratory distress.
Aim:
INSURE (INtubation, SURfactant, Extubation) is a proven complement of nasal CPAP (nCPAP) for respiratory distress syndrome (RDS) treatment of preterm infants. Early administration is characterized by greater success. We aimed to determine the efficacy and failure or other respiratory outcomes of INSURE administration during nasal continous positive airway pressure (nCPAP) treatment of RDS.
Methods:
Among 824 premature infants neonatal intensive care unit (NICU) admitted at Padua University Hospital during 2007-2009, 209 (25.4%) were managed by surfactant replacement (200 mg/kg, Curosurf®) if required >45% oxygen ("rescue" treatment), including 42 (20.1%) during nCPAP. Each premature infant treated with INSURE during nasal CPAP was compared to 2 consecutive control infants treated with surfactant during mechanical ventilation, matched for antenatal steroids, delivery route, gestational age, and sex.
Results:
Infants with RDS, treated with nCPAP and INSURE-complement (N.=25), were comparable in Apgar score, need of PPV at birth, birth weight, pre-surfactant FiO2 and timing of surfactant replacement to controls. However, nCPAP and INSURE-complement was superior in terms both of oxygenation, evaluated as post-treatment FiO2 (Median, [IQR], 26 [21-40] vs. 21 [21-29]; P=0.03) and (a-A) pO2 (0.48 [0.45-0.60] vs. 0.58 [0.53-0.72]; P=0.03). The improved oxygenation was sustained over the following days. In addition, premature infants treated with nCPAP and INSURE-complement developed less respiratory co-morbidities, including pneumothorax, borncopulmonary disease (BPD), and BPD and death (P=0.04).
Conclusion:
INSURE-complement of nasal CPAP has a superior efficacy in terms of oxygenation improvement, maintenance of optimal oxygenation, and reduction of respiratory comorbidities respect to "rescue" surfactant administration during mechanical ventilation.
Related Concept Videos
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Suctioning the Nasopharyngeal Airway
Equipment Required
Acute Respiratory Failure-IV
Administering Oxygen by Nasal Cannula
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils, connected...